Menu

Integra LifeSciences Holdings Corporation IART

Full chart Compare
Set alert

Price alert · IART

All alert types
14.37 USD +0.95 (+7.08%)

At closeNov 10, 2026, 6:41 AM EST

14.38 +0.01 +0.07%

Pre-market · Nov 10, 6:41 AM ET

13.42 Day range 14.40
8.70 52-week range 20.49
YTD
+15.70%
1 year
+17.98%

Revenue & Expenses

Other Income → Expenses: $16.12MIncome Tax Benefit → Expenses: $47.03MExpenses → Selling, General & Admin: $699.70MExpenses → Research & Development: $98.97MExpenses → Other Operating Expenses: $526.32MExpenses → Interest Expense: $86.25MGross Profit → Expenses: $831.62MRevenue → Gross Profit: $831.62MRevenue → Cost of Revenue: $803.63MNet Loss → Expenses: $516.47MOther Income$16.12MIncome Tax Benefit$47.03MGross Profit$831.62MNet Loss$516.47MCost of Revenue$803.63MExpenses$1.41BSelling, General & Admin$699.70MResearch & Development$98.97MOther Operating Expenses$526.32MInterest Expense$86.25MRevenue$1.64B

Latest period ending Dec 31, 2025 · select a line to chart its full history

IART annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.64B1.61B1.54B1.56B1.54B
831.62M882.06M884.74M970.31M944.64M
-493.37M28.41M111.53M238.92M197.23M
-516.47M-6.94M67.74M180.55M169.07M
-6.74-0.090.842.161.98
IART annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
235.05M246.38M276.40M456.66M513.45M
3.60B4.04B3.78B3.89B3.78B
2.56B2.49B2.19B2.09B2.10B
2.03B1.98B1.68B1.62B1.65B
1.04B1.55B1.59B1.80B1.68B
IART annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
50.38M129.38M139.96M264.47M312.43M
-108.06M-390.81M-94.18M-58.58M-161.44M
28.34M237.86M-229.93M-251.95M-98.23M
-81.44M-104.42M-66.86M-31.20M-48.02M
-11.33M-30.03M-180.26M-56.79M43.28M